Abstract Library
Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.
Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.
ENETS Abstract Search
Introduction: Temozolomide (TMZ) and dacarbazine (DTIC) are alkylating agents (ALK) with antitumor efficacy in metastatic PanNET. Rechallenging ALK following prior efficacy is commonly performed but has not been evaluated.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author:
Authors: De Rycke O, Walter T, Perrier M, Hentic O, Lombard-Bohas C,
Keywords: alkylating agents, pancreatic NET, re-challenge, chemotherapy,
Introduction: The 5-fluorouracile (5FU) + dacarbazine (DTIC) combination has been poorly evaluated in NET
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author: de Mestier L
Authors: De Mestier L, Cros J, Hentic O, Legoux J, Muller N,
Keywords: chemotherapy, tumor response, tolerance, pfs,
#1706 Effectiveness of Chemoterapy in Advanced PanNETs with ki67<55%: Monocentric Experience
Introduction: Pancreatic Neuroendocrine Tumors (panNETs) are neoplasms with heterogeneous clinical behaviour. There is no standard treatment.
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author:
Authors: Antista M, Cingarlini S, Grego E, Ortolani S, Scarpa A,
Keywords: chemotherapy, neuroendocrine, pan NETs, ki67<55%,
#1537 Antitumor Efficacy of Temozolomide in Patients with Metastatic Pulmonary Carcinoids
Introduction: Temodal (TMZ) is an oral alternative to dacarbazine.
Conference: 13th Annual ENETSConcerence (2016)
Presenting Author:
Authors: Bello Roufai D, Planchard D, Walter T, Berdelou A, Guigay J,
Keywords: pulmonary carcinoids, temozolomide, safety,
#1396 3-Drugs Chemotherapy Regimen for G3 PanNENs with Ki67 below 55%: Single Institution Experience
Introduction: To date no standard regimen of chemotherapy (CTH) is universally approved for advanced pancreatic neuroendocrine neoplasms (PanNENs) with Ki67
Conference: 13th Annual ENETSConcerence (2016)
Presenting Author: Grego E
Authors: Grego E, Cingarlini S, Ortolani S, Crosara S, De Robertis R,
Keywords: 3-drugs chemotherapy regimen, pancreatic nets, ki-67% <55%,